N	Concordance
1	estern blot, lymphoproliferation assay, cytotoxic T-cell lysis, CD8-depleted co-
2	er strains of mice and develop a weaker cytotoxic T-cell response upon challenge
3	 ting Epstein-Barr virus (EBV)-specific cytotoxic T-cell lines from patients wit
4	        BACKGROUND: Recipient antidonor cytotoxic T-cell activity has been assoc
5	e activation. The vigorous polyspecific cytotoxic T-cell (CTL) response directed
6	Gene transfer was applied to the murine cytotoxic T-cell line cl96. All recombin
7	 also capable of inducing a strong CD8+ cytotoxic T-cell (CTL) response in immun
8	tricted peptide representing a dominant cytotoxic T-cell epitope, in patients w
9	o patients. In both cases, several CD4+ cytotoxic T-cell (CTL) clones were estab
10	tural-killer-cell-stimulatory factor or cytotoxic-T-cell-maturation factor. Thes
11	r burden. In this model, tumor-specific cytotoxic T-cells (CTL) could also be in
12	of DCs. Also, IL-12 blocks apoptosis of cytotoxic T-cells and DCs.  Other potent
13	es of splenic B and T lymphocytes or of cytotoxic T-cells. Neither did they chan